Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.10p
   
  • Change Today:
      0.100p
  • 52 Week High: 12.10
  • 52 Week Low: 6.60
  • Currency: UK Pounds
  • Shares Issued: 6,332m
  • Volume: 635,467
  • Market Cap: £576.26m
  • RiskGrade: 268
  • Beta: 0.00

Latest ShareCast News

Results of General Meeting

By Sharecast

Date: Monday 29 Dec 2025

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

Allergy Therapeutics confident in funding as results remain late

By Josh White

Date: Friday 20 Jan 2023

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.

Allergy Therapeutics pauses production at Freema... 04-Oct-2022 ShareCast
Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast
Allergy Therapeutics upbeat on ex-vivo study of ... 03-Aug-2021 ShareCast
Allergy Therapeutics FY profits seen 'well ahead... 24-Jun-2021 ShareCast
Allergy Therapeutics completes treatment in G309... 06-May-2021 ShareCast
Allergy Therapeutics reports record pre-R&D oper... 03-Mar-2021 ShareCast
Allergy Therapeutics trades in line, H1 revenues... 13-Jan-2021 ShareCast
Allergy Therapeutics begins peanut allergy vacci... 05-Jan-2021 ShareCast
Allergy Therapeutics screens first patients in g... 26-Oct-2020 ShareCast
Allergy Therapeutics signs new vaccine deal with... 03-Sep-2020 ShareCast
Allergy Therapeutics revenues grow despite Covid... 15-Jul-2020 ShareCast
Allergy Therapeutics pleased with invalidation o... 09-Jul-2020 ShareCast
Allergy Therapeutics on track to 'significantly'... 24-Jun-2020 ShareCast
Allergy Therapeutics to take 'stepwise approach'... 26-Nov-2019 ShareCast
Allergy Therapeutics earnings set to top expecta... 27-Jun-2019 ShareCast
Allergy Therapeutics flags positive outcomes fro... 20-May-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 9.10p
Change Today 0.100p
% Change 1.11 %
52 Week High 12.10
52 Week Low 6.60
Volume 635,467
Shares Issued 6,332m
Market Cap £576.26m
Beta 0.00
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 26-May-2026

Time Volume / Share Price
16:35 16,000 @ 9.10p
16:35 1,000 @ 9.10p
16:35 5,000 @ 9.10p
16:35 10,000 @ 9.10p
15:54 17,075 @ 8.79p

AGY Key Personnel

CEO Manuel Llobet

Top of Page